NGM BIOPHARMACEUTICALS INC Operating Lease, Liability, Current
NGM BIOPHARMACEUTICALS INC had Operating Lease, Liability, Current of $0 as of 2023-12-31, per its 10-K filed 2024-03-11.
Discontinued › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2024-03-11
- 2023-12-31: Operating Lease, Liability, Current $0.00.
- 2023-09-30: Operating Lease, Liability, Current $1.38M.
- 2023-06-30: Operating Lease, Liability, Current $2.75M.
- 2023-03-31: Operating Lease, Liability, Current $4.07M.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-11 |
| 2023-09-30 | $1.38M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $2.75M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $4.07M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $5.38M 10-K · filed 2024-03-11 |
| 2022-09-30 | $5.31M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $5.23M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $5.15M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $5.08M 10-K · filed 2023-02-28 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-01 |